Skip to main page content
Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

My NCBI Filters
Results by year

Table representation of search results timeline featuring number of search results per year.

Year Number of Results
1993 1
1994 1
1996 4
1997 2
1998 4
1999 5
2000 1
2001 1
2002 1
2003 1
2004 5
2005 9
2006 5
2007 5
2008 3
2009 3
2010 2
2011 2
2012 4
2013 3
2014 2
2015 4
2016 3
2017 5
2018 4
2019 3
2020 2
Text availability
Article attribute
Article type
Publication date

Search Results

85 results
Results by year
Filters applied: . Clear all
Page 1
Characterization of hemostasis in mice lacking the novel thrombosis susceptibility gene Slc44a2.
Tilburg J, Adili R, Nair TS, Hawley ME, Tuk DC, Jackson M, Spronk HM, Versteeg HH, Carey TE, van Vlijmen BJM, Maracle CX, Holinstat M. Tilburg J, et al. Among authors: van Vlijmen BJM. Thromb Res. 2018 Nov;171:155-159. doi: 10.1016/j.thromres.2018.09.057. Epub 2018 Sep 26. Thromb Res. 2018. PMID: 30312801 Free PMC article.
Mouse venous thrombosis upon silencing of anticoagulants depends on tissue factor and platelets, not FXII or neutrophils.
Heestermans M, Salloum-Asfar S, Streef T, Laghmani EH, Salvatori D, Luken BM, Zeerleder SS, Spronk HMH, Korporaal SJ, Kirchhofer D, Wagenaar GTM, Versteeg HH, Reitsma PH, Renné T, van Vlijmen BJM. Heestermans M, et al. Among authors: van Vlijmen BJM. Blood. 2019 May 9;133(19):2090-2099. doi: 10.1182/blood-2018-06-853762. Epub 2019 Mar 21. Blood. 2019. PMID: 30898865
Multiplexed targeted proteomic assay to assess coagulation factor concentrations and thrombosis-associated cancer.
Mohammed Y, van Vlijmen BJ, Yang J, Percy AJ, Palmblad M, Borchers CH, Rosendaal FR. Mohammed Y, et al. Among authors: van Vlijmen BJ. Blood Adv. 2017 Jun 20;1(15):1080-1087. doi: 10.1182/bloodadvances.2017007955. eCollection 2017 Jun 27. Blood Adv. 2017. PMID: 29296750 Free PMC article.
Predilection of Low Protein C-induced Spontaneous Atherothrombosis for the Right Coronary Sinus in Apolipoprotein E deficient mice.
Heestermans M, Ouweneel AB, Hassan J, Kloosterman M, Reitsma PH, Gijbels MJJ, van Vlijmen BJM, van Eck M. Heestermans M, et al. Among authors: van Vlijmen BJM. Sci Rep. 2018 Oct 10;8(1):15106. doi: 10.1038/s41598-018-32584-y. Sci Rep. 2018. PMID: 30305662 Free PMC article.
The Impact of Dose and Simultaneous Use of Acid-Reducing Agents on the Effectiveness of Vemurafenib in Metastatic BRAF V600 Mutated Melanoma: a Retrospective Cohort Study.
Knapen LM, Koornstra RHT, Driessen JHM, van Vlijmen B, Croes S, Schalkwijk S, Colbers A, Gerritsen WR, Burger DM, de Vries F, van Erp NP. Knapen LM, et al. Among authors: van Vlijmen B. Target Oncol. 2018 Jun;13(3):363-370. doi: 10.1007/s11523-018-0564-3. Target Oncol. 2018. PMID: 29644577 Free PMC article.
Correction of a dominant-negative von Willebrand factor multimerization defect by small interfering RNA-mediated allele-specific inhibition of mutant von Willebrand factor.
de Jong A, Dirven RJ, Oud JA, Tio D, van Vlijmen BJM, Eikenboom J. de Jong A, et al. Among authors: van Vlijmen BJM. J Thromb Haemost. 2018 Jul;16(7):1357-1368. doi: 10.1111/jth.14140. Epub 2018 Jun 1. J Thromb Haemost. 2018. PMID: 29734512 Free article.
85 results
Jump to page
Feedback